TET2 and colorectal carcinoma: To investigate the mechanism of downregulation of TET2 in Ob-CRC, human CRC cell lines HT29 and HT116 were treated with metabolic factors, such as glucose, insulin, a saturated fatty acid (palmitic acid [PA]), and an unsaturated fatty acid (oleic acid [OA]).